Overview

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To test whether the current custom of initiating treatment for hypertension with a single drug is less effective in the short-term than initial combination therapy, and results in the eventual need for comparatively more antihypertensive drug therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cambridge
Collaborator:
British Heart Foundation
Treatments:
Hydrochlorothiazide
Losartan